NASDAQ: SNOA
Sonoma Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their SNOA stock forecasts and price targets.

Forecast return on equity

Is SNOA forecast to generate an efficient return?

Company
-59.39%
Industry
30.55%
Market
76.96%
SNOA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SNOA forecast to generate an efficient return on assets?

Company
-21.16%
Industry
12.71%
SNOA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SNOA earnings per share forecast

What is SNOA's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$1.79

SNOA vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
SNOA$2.22N/AN/A
SBFM$1.29$15.00+1,062.79%Strong Buy
EVOK$2.33N/AN/A
SXTC$1.02N/AN/A
PRFX$2.10N/AN/A

Sonoma Pharmaceuticals Stock Forecast FAQ

What is SNOA's earnings growth forecast for 2026-2026?

(NASDAQ: SNOA) Sonoma Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 80.88%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 71.14%.

Sonoma Pharmaceuticals's earnings in 2025 is -$3,748,000.

In 2026, SNOA is forecast to generate -$2,892,219 in earnings, with the lowest earnings forecast at -$2,892,219 and the highest earnings forecast at -$2,892,219.

If you're new to stock investing, here's how to buy Sonoma Pharmaceuticals stock.

What is SNOA's forecast return on equity (ROE) for 2026-2026?

(NASDAQ: SNOA) forecast ROE is -59.39%, which is considered weak.

What is SNOA's Earnings Per Share (EPS) forecast for 2026-2026?

(NASDAQ: SNOA) Sonoma Pharmaceuticals's current Earnings Per Share (EPS) is -$2.42. In 2026, SNOA's EPS is forecast to hit -$1.79 (min: -$1.79, max: -$1.79).

What is SNOA's forecast return on assets (ROA) for 2026-2026?

(NASDAQ: SNOA) forecast ROA is -21.16%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 12.71%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.